Tigal80
2021-08-31
yes
Why Moderna Shares Dropped Lower Monday
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
3
4
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":818153677,"tweetId":"818153677","gmtCreate":1630387484299,"gmtModify":1704959536198,"author":{"id":3575390834397772,"idStr":"3575390834397772","authorId":3575390834397772,"authorIdStr":"3575390834397772","name":"Tigal80","avatar":"https://static.tigerbbs.com/86f76710483a16eae0642572ffa5f1be","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":11,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>yes</p></body></html>","htmlText":"<html><head></head><body><p>yes</p></body></html>","text":"yes","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/818153677","repostId":1198650198,"repostType":4,"repost":{"id":"1198650198","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1630386810,"share":"https://www.laohu8.com/m/news/1198650198?lang=&edition=full","pubTime":"2021-08-31 13:13","market":"us","language":"en","title":"Why Moderna Shares Dropped Lower Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1198650198","media":"Benzinga","summary":"Moderna Inc MRNA 3.02%shares closed almost 3% lower in the regular session on Monday.\nWhat’s Moving?","content":"<p><b>Moderna Inc</b> MRNA 3.02%shares closed almost 3% lower in the regular session on Monday.</p>\n<p><b>What’s Moving?</b> The decline in Moderna shares comes as the U.S. Centers for Disease Control and Prevention explores if a third shot of the COVID-19 vaccine should be provided to the masses.</p>\n<p>On Monday, CDC scientist <b>Sara Oliver</b> said at an advisory group meeting that data required to evaluate COVID-19 booster shots for the general population is limited, CNBCreported.</p>\n<p>Vaccines that require more than <a href=\"https://laohu8.com/S/AONE.U\">one</a> dose do not necessarily mean that annual boosters are needed,” said the scientist.</p>\n<p>Shares of COVID-19 vaccine makers slipped post the news. Moderna shares closed 3.02% lower at $370.69 in the regular session and fell 0.85% to $367.53 in the after-hours trading.</p>\n<p>Shares of <b>BioNTech Inc SE</b> BNTX 3.76%, which makes a COVID-19 vaccine in partnership with <b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a> Inc</b> PFE 0.26%, closed 3.76% lower at $345 in the regular session. Pfizer shares closed 0.34% at $46.76.</p>\n<p><b>Why It Matters:</b> Moderna shares have shot up 254.83% since the year began emerging as the best performer on the S&P 500 Index.</p>\n<p>Oliver’s presentation at the meeting suggests that the advisory group may initially limit its recommendations for vaccine boosters to vulnerable groups and healthcare workers, CNBC noted.</p>\n<p>This in turn would lead to less demand for the vaccine and thus affect the bottom lines of the manufacturers.</p>\n<p>Meanwhile, Moderna’scontamination troublesin Japan have intensified as two more regions of the country havetemporarily haltedthe administration of its COVID-19 vaccine, reported Reuters.</p>\n<p>The Japanese government reportedly said over Sunday that two people died after receiving the Moderna vaccine from the contaminated lots that have been suspended. Those deaths are now under investigation.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Shares Dropped Lower Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Shares Dropped Lower Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-08-31 13:13</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Moderna Inc</b> MRNA 3.02%shares closed almost 3% lower in the regular session on Monday.</p>\n<p><b>What’s Moving?</b> The decline in Moderna shares comes as the U.S. Centers for Disease Control and Prevention explores if a third shot of the COVID-19 vaccine should be provided to the masses.</p>\n<p>On Monday, CDC scientist <b>Sara Oliver</b> said at an advisory group meeting that data required to evaluate COVID-19 booster shots for the general population is limited, CNBCreported.</p>\n<p>Vaccines that require more than <a href=\"https://laohu8.com/S/AONE.U\">one</a> dose do not necessarily mean that annual boosters are needed,” said the scientist.</p>\n<p>Shares of COVID-19 vaccine makers slipped post the news. Moderna shares closed 3.02% lower at $370.69 in the regular session and fell 0.85% to $367.53 in the after-hours trading.</p>\n<p>Shares of <b>BioNTech Inc SE</b> BNTX 3.76%, which makes a COVID-19 vaccine in partnership with <b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a> Inc</b> PFE 0.26%, closed 3.76% lower at $345 in the regular session. Pfizer shares closed 0.34% at $46.76.</p>\n<p><b>Why It Matters:</b> Moderna shares have shot up 254.83% since the year began emerging as the best performer on the S&P 500 Index.</p>\n<p>Oliver’s presentation at the meeting suggests that the advisory group may initially limit its recommendations for vaccine boosters to vulnerable groups and healthcare workers, CNBC noted.</p>\n<p>This in turn would lead to less demand for the vaccine and thus affect the bottom lines of the manufacturers.</p>\n<p>Meanwhile, Moderna’scontamination troublesin Japan have intensified as two more regions of the country havetemporarily haltedthe administration of its COVID-19 vaccine, reported Reuters.</p>\n<p>The Japanese government reportedly said over Sunday that two people died after receiving the Moderna vaccine from the contaminated lots that have been suspended. Those deaths are now under investigation.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1198650198","content_text":"Moderna Inc MRNA 3.02%shares closed almost 3% lower in the regular session on Monday.\nWhat’s Moving? The decline in Moderna shares comes as the U.S. Centers for Disease Control and Prevention explores if a third shot of the COVID-19 vaccine should be provided to the masses.\nOn Monday, CDC scientist Sara Oliver said at an advisory group meeting that data required to evaluate COVID-19 booster shots for the general population is limited, CNBCreported.\nVaccines that require more than one dose do not necessarily mean that annual boosters are needed,” said the scientist.\nShares of COVID-19 vaccine makers slipped post the news. Moderna shares closed 3.02% lower at $370.69 in the regular session and fell 0.85% to $367.53 in the after-hours trading.\nShares of BioNTech Inc SE BNTX 3.76%, which makes a COVID-19 vaccine in partnership with Pfizer Inc PFE 0.26%, closed 3.76% lower at $345 in the regular session. Pfizer shares closed 0.34% at $46.76.\nWhy It Matters: Moderna shares have shot up 254.83% since the year began emerging as the best performer on the S&P 500 Index.\nOliver’s presentation at the meeting suggests that the advisory group may initially limit its recommendations for vaccine boosters to vulnerable groups and healthcare workers, CNBC noted.\nThis in turn would lead to less demand for the vaccine and thus affect the bottom lines of the manufacturers.\nMeanwhile, Moderna’scontamination troublesin Japan have intensified as two more regions of the country havetemporarily haltedthe administration of its COVID-19 vaccine, reported Reuters.\nThe Japanese government reportedly said over Sunday that two people died after receiving the Moderna vaccine from the contaminated lots that have been suspended. Those deaths are now under investigation.","news_type":1},"isVote":1,"tweetType":1,"viewCount":227,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":3,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/818153677"}
精彩评论